Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Atopic Eczema”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04018027
What this trial is testing

Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis

Who this might be right for
PruritusAtopic Dermatitis
Cara Therapeutics, Inc. 401
Testing effectiveness (Phase 2)Ended earlyNCT06058156
What this trial is testing

Phase 2 Study of SAR444656 in Adult Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Sanofi 70
Early research (Phase 1)Study completedNCT00833079
What this trial is testing

Bioequivalence of Two Tacrolimus 0.1% Topical Ointment Formulations in Patients With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Sun Pharmaceutical Industries, Inc. 500
Testing effectiveness (Phase 2)Study completedNCT04179760
What this trial is testing

Safety and Efficacy of SCM-AGH in Subjects With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
SCM Lifescience Co., LTD. 92
Large-scale testing (Phase 3)Study completedNCT03952559
What this trial is testing

Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 516
Testing effectiveness (Phase 2)Study completedNCT02210780
What this trial is testing

Study of Dupilumab and Immune Responses in Adults With Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Regeneron Pharmaceuticals 194
Large-scale testing (Phase 3)Study completedNCT04250350
What this trial is testing

Study to Assess the Safety and Efficacy of Lebrikizumab (LY3650150) in Adolescent Participants With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 206
Testing effectiveness (Phase 2)Ended earlyNCT03654755
What this trial is testing

Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Asana BioSciences 162
Large-scale testing (Phase 3)Looking for participantsNCT07309055
What this trial is testing

SHR-1819 Injection in Adolescents With Severe Atopic Dermatitis

Who this might be right for
Adolescents With Moderate-to-severe Atopic Dermatitis
Guangdong Hengrui Pharmaceutical Co., Ltd 201
Testing effectiveness (Phase 2)Study completedNCT03100344
What this trial is testing

Dose-ranging Study of Nemolizumab in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Galderma R&D 226
Not applicableActive Not RecruitingNCT07582237
What this trial is testing

Long-Term Follow-up Study of FURESTEM-AD in Patients With Atopic Dermatitis(K0106)

Who this might be right for
Dermatitis, Atopic
Kang Stem Biotech Co., Ltd. 262
Large-scale testing (Phase 3)Study completedNCT03575871
What this trial is testing

Study Evaluating Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Pfizer 391
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07175233
What this trial is testing

Evaluate the Efficacy, Safety of SIM0278 in Subjects With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Jiangsu Simcere Pharmaceutical Co., Ltd. 184
Early research (Phase 1)Looking for participantsNCT06564389
What this trial is testing

FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

Who this might be right for
Healthy ParticipantsAtopic Dermatitis
Pfizer 119
Not applicableUnknownNCT05178433
What this trial is testing

Skin Care Strategies for Neonatal Jaundice Phototherapy to Prevent Atopic Dermatitis in Moderate and Severe Infants

Who this might be right for
Neonatal JaundiceAtopic Dermatitis
Shanghai First Maternity and Infant Hospital 200
Testing effectiveness (Phase 2)Ended earlyNCT04791319
What this trial is testing

Bermekimab (JNJ-77474462) in the Treatment of Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Janssen Research & Development, LLC 199
Large-scale testing (Phase 3)Study completedNCT03334422
What this trial is testing

Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 615
Testing effectiveness (Phase 2)Study completedNCT05641558
What this trial is testing

Evaluation of 611 in Chinese Adult Patients With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT05017480
What this trial is testing

Evaluate the Efficacy and Safety of CBP-201 in Moderate to Severe Atopic Dermatitis in China

Who this might be right for
Moderate-to-severe Atopic Dermatitis
Connect Biopharm LLC 330
Large-scale testing (Phase 3)Study completedNCT02260986
What this trial is testing

Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Regeneron Pharmaceuticals 740
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation